{
  "id": "2247620991_2",
  "title": "正大天晴 HER2 双抗首次启动 III 期临床",
  "content": "<div class=\"rich_media_content js_underline_content autoTypeSetting24psection\" id=\"js_content\">\n <section data-mpa-action-id=\"mcn8unk11r0i\" data-pm-slice=\"0 0 []\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;\">\n  <a class=\"weapp_image_link js_weapp_entry\" data-miniprogram-appid=\"wx33d4c3735820a33e\" data-miniprogram-applink=\"\" data-miniprogram-imageurl=\"https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vROvmPqd90D6qZZzHhQwNBck2THhGajmUBOiaz7dPLTUw4LGrUazBPtVTYLDmWibvichjicrGCtRyWDg/640?wx_fmt=png&amp;from=appmsg\" data-miniprogram-nickname=\"Insight医药情报助手\" data-miniprogram-path=\"pages/index/index\" data-miniprogram-servicetype=\"0\" data-miniprogram-type=\"image\" style=\"\">\n   <img class=\"rich_pages wxw-img\" data-imgfileid=\"100133179\" data-ratio=\"0.26382978723404255\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vROvmPqd90D6qZZzHhQwNBck2THhGajmUBOiaz7dPLTUw4LGrUazBPtVTYLDmWibvichjicrGCtRyWDg/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n  </a>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    近日，正大天晴\n   </span>\n  </span>\n  <span data-pm-slice=\"0 0 []\" leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: normal;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;visibility: visible;'>\n   在\n  </span>\n  <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;'>\n   <span leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;font-style: normal;font-weight: normal;visibility: visible;'>\n    ClinicalTrials.gov 官网上登记了一项\n   </span>\n   <span leaf=\"\">\n    TQB2930 用于\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     HER2 阳性乳腺癌\n    </span>\n   </span>\n   <span leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;font-style: normal;font-weight: normal;visibility: visible;'>\n    的 III 期临床试验\n    <span style=\"color: rgb(178, 178, 178);\" textstyle=\"\">\n     （\n    </span>\n   </span>\n   <span leaf=\"\">\n    <span style=\"color: rgb(178, 178, 178);\" textstyle=\"\">\n     NCT07047365\n    </span>\n   </span>\n   <span data-pm-slice=\"0 0 []\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;visibility: visible;\">\n    <span leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;font-style: normal;font-weight: normal;visibility: visible;'>\n     <span style=\"color: rgb(178, 178, 178);\" textstyle=\"\">\n      ）\n     </span>\n    </span>\n   </span>\n   <span leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;font-style: normal;font-weight: normal;visibility: visible;'>\n    。公开资料显示，这是该药启动的\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     首个\n    </span>\n    III 期。\n   </span>\n  </span>\n </section>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100137335\" data-ratio=\"0.2641509433962264\" data-s=\"300,640\" data-type=\"png\" data-w=\"1007\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8spkkeMz6z17icUbDAyiagMItniafOH97niaiaO4GCf3DIMibTLpdrp9G39qMVCzaHVDybuX5Mp0YXhCKbg/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;text-align: center;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    截图来源：\n   </span>\n  </span>\n  <span data-pm-slice=\"0 0 []\" style='color: rgb(178, 178, 178);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.408px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n   <span leaf=\"\">\n    <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n     ClinicalTrials.gov 官网\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;'>\n   <span leaf=\"\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.034em;font-style: normal;font-weight: normal;visibility: visible;'>\n    这是一项\n   </span>\n   <span leaf=\"\">\n    随机、开放、平行对照、多中心 III 期临床研究，旨在\n   </span>\n   <span leaf=\"\">\n    评估 TQB2930 联合研究者选择的化疗与\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     曲妥珠单抗\n    </span>\n    联合研究者选择的化疗治疗 HER2 阳性晚期乳腺癌的有效性和安全性。该研究拟入组 416 人，主要终点是 PFS。给药方案如下：\n   </span>\n  </span>\n </section>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100137336\" data-ratio=\"0.6242362525458248\" data-s=\"300,640\" data-type=\"png\" data-w=\"982\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8spkkeMz6z17icUbDAyiagMItuSdUeTtJqF4ZhyvNyF9O2kzuxT1Wa0CFf63BFGI8FGkvGg3icJsgqww/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"2 3 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;text-align: center;\">\n  <span leaf=\"\">\n   <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    截图来源：\n   </span>\n  </span>\n  <span data-pm-slice=\"0 0 []\" style='color: rgb(178, 178, 178);font-family: mp-quote, \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 12px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.408px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;'>\n   <span leaf=\"\">\n    <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n     ClinicalTrials.gov 官网\n    </span>\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;visibility: visible;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;visibility: visible;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    TQB2930 是正大天晴自主研发的一款靶向\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    HER2 的双特异性抗体\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，一端靶向 HER2 的 ECD2 抗原表位\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （帕妥珠单抗结合位点）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，另一端互补结合 HER2 的 ECD4 抗原表位\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （曲妥珠单抗结合位点）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin-top: 0px;padding: 0px;outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    2024 年 ASCO 大会上，正大天晴首次公布了\n   </span>\n  </span>\n  <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n   <span leaf=\"\">\n    <span style=\"font-size: 15px;\" textstyle=\"\">\n     TQB2930 在乳腺癌患者中的 Ib 期临床研究\n    </span>\n    <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n     （NCT06202261）\n    </span>\n    <span style=\"font-size: 15px;\" textstyle=\"\">\n     数据：\n    </span>\n   </span>\n  </span>\n  <span style='-webkit-tap-highlight-color: transparent;margin-top: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: mp-quote, -apple-system-font, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-size: 15px;letter-spacing: 0.034em;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n   <span leaf=\"\">\n    <span style=\"font-size: 15px;\" textstyle=\"\">\n     31 例受试者可疗效评价，\n    </span>\n    <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n     ORR 为 25.8%，其中 PR 8 例；mPFS 为 5.5 个月\n    </span>\n    <span style=\"font-size: 15px;\" textstyle=\"\">\n     。\n    </span>\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;visibility: visible;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;visibility: visible;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    2025 年 ASCO 大会上公布的是该试验中队列 4 的数据，旨在\n   </span>\n  </span>\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"section\",\"attributes\":{\"data-pm-slice\":\"2 2 []\",\"style\":\"margin-left: 8px; margin-right: 8px; margin-bottom: 24px; line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;visibility: visible;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    评估 TQB2930 联合化疗对至少接受过两线治疗的 HER2 阳性乳腺癌患者的安全性和有效性。\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    截至 2024 年 12 月 15 日，已有 55 例患者接受了 TQB2930 联合化疗治疗。中位随访时间为 4.14 个月。在 52 例可评估疗效的患者中，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    ORR 为 48.1%\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，其中\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    88.5%\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);font-weight: bold;\" textstyle=\"\">\n    （46/52）\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    的患者靶病灶缩小\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"section\",\"attributes\":{\"data-pm-slice\":\"2 2 []\",\"style\":\"margin-left: 8px; margin-right: 8px; margin-bottom: 24px; line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    中位 PFS 和 OS 尚未达到，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    6 个月 PFS 率估计为 71%。\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;'>\n  <span leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    在既往接受 T-DM1 治疗但疾病进展的患者中，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    ORR 为 36.8%\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    ，而接受其他 HER2-ADC\n   </span>\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    （包括\n   </span>\n  </span>\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"section\",\"attributes\":{\"data-pm-slice\":\"2 2 []\",\"style\":\"margin-left: 8px; margin-right: 8px; margin-bottom: 24px; line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;color: rgb(178, 178, 178);\" textstyle=\"\">\n    RC48、DS-8201 等）\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    治疗失败的患者中，\n   </span>\n   <span style=\"font-size: 15px;font-weight: bold;\" textstyle=\"\">\n    ORR 为 50%\n   </span>\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    。\n   </span>\n  </span>\n </section>\n <section data-pm-slice=\"2 2 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px 8px 24px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;white-space: normal;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-family: \"PingFang SC\", system-ui, -apple-system, \"system-ui\", \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);line-height: 1.75em;'>\n  <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"section\",\"attributes\":{\"data-pm-slice\":\"2 2 []\",\"style\":\"margin-left: 8px; margin-right: 8px; margin-bottom: 24px; line-height: 1.75em;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\" style=\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;\">\n   <span style=\"font-size: 15px;\" textstyle=\"\">\n    在安全性方面，≥3 级 TRAE 主要为血液学不良反应，包括白细胞计数下降、中性粒细胞减少、血小板减少和输液相关反应。未发生 ≥3 级心脏毒性，窦性心动过缓或 QT 间期延长的发生率&lt;3%。\n   </span>\n  </span>\n </section>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100137340\" data-ratio=\"0.37222222222222223\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8spkkeMz6z17icUbDAyiagMItFMIfQ2JlKnvD74BPqoZ6IjSlBeC0sktibQrxBWk6noe5EUWm6ibcGdGg/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;text-align: center;\">\n  <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n   <span leaf=\"\">\n    <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n     截图来源：Insight 数据库\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;'>\n   <span leaf=\"\">\n    Insight 数据库显示，全球范围内共有 6 款 HER2 双抗进入临床阶段，\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     百济神州\n    </span>\n    的\n   </span>\n   <span leaf=\"\">\n    泽尼达妥单抗已于上半年获 NMPA\n    <a class=\"normal_text_link\" data-itemshowtype=\"0\" data-linktype=\"2\" href=\"https://mp.weixin.qq.com/s?__biz=Mzk3NTA3Nzc2Ng==&amp;mid=2247619135&amp;idx=2&amp;sn=7d41d20a3fc421b5869ad4fdb360a944&amp;scene=21#wechat_redirect\" linktype=\"text\" style=\"\" target=\"_blank\" textvalue=\"批准\">\n     批准\n    </a>\n    用于\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     胆道癌\n    </span>\n    。除此之外，\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     正大天晴\n    </span>\n   </span>\n   <span leaf=\"\">\n    TQB2930 和\n    <span style=\"font-weight: bold;\" textstyle=\"\">\n     康宁杰瑞/石药集团\n    </span>\n   </span>\n   <span leaf=\"\">\n    Anbenitamab-KN-026 已进入 III 期临床。\n   </span>\n  </span>\n </section>\n <section nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100137341\" data-ratio=\"0.4842592592592593\" data-s=\"300,640\" data-type=\"png\" data-w=\"1080\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8spkkeMz6z17icUbDAyiagMItBSJfq6YvZtJpJ88Zmwk4UeVCL0pztUlvkcVxHNmOvx911G031shPGw/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;\">\n  <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-align: justify;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;'>\n   <section data-mpa-action-id=\"mcn8unk11pyw\" data-pm-slice=\"0 0 []\" style=\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;text-align: center;\">\n    <span data-pm-slice=\"0 0 []\" style='-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-family: \"PingFang SC\", system-ui, -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;'>\n     <span data-pm-slice='1 1 [\"para\",{\"tagName\":\"section\",\"attributes\":{\"style\":\"margin-left: 8px;margin-right: 8px;line-height: 1.75em;margin-bottom: 24px;text-align: center;\",\"data-mpa-action-id\":\"mcn8unk11pyw\",\"data-pm-slice\":\"0 0 []\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"},\"node\",{\"tagName\":\"span\",\"attributes\":{\"data-pm-slice\":\"0 0 []\",\"style\":\"-webkit-tap-highlight-color: transparent;margin: 0px;padding: 0px;outline: 0px;max-width: 100%;color: rgba(0, 0, 0, 0.9);font-family: \\\"PingFang SC\\\", system-ui, -apple-system, BlinkMacSystemFont, \\\"Helvetica Neue\\\", \\\"Hiragino Sans GB\\\", \\\"Microsoft YaHei UI\\\", \\\"Microsoft YaHei\\\", Arial, sans-serif;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;font-size: 15px;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;\"},\"namespaceURI\":\"http://www.w3.org/1999/xhtml\"}]' leaf=\"\">\n      <span style=\"font-size: 12px;color: rgb(178, 178, 178);\" textstyle=\"\">\n       截图来源：Insight 数据库\n      </span>\n     </span>\n    </span>\n   </section>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk112m4\" style='margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;text-align: left;'>\n  <span style=\"outline: 0px;font-size: 12px;visibility: visible;color: rgb(163, 163, 163);\">\n   <strong style=\"outline: 0px;letter-spacing: 0.544px;visibility: visible;\">\n    <span leaf=\"\">\n     封面来源：\n    </span>\n   </strong>\n   <span style='outline: 0px;visibility: visible;font-family: -apple-system, system-ui, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;letter-spacing: 0.544px;'>\n    <span leaf=\"\">\n     企业 Logo\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk1afw\" style='margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;text-align: left;'>\n  <span style=\"outline: 0px;font-size: 15px;visibility: visible;color: rgb(178, 178, 178);\">\n   <strong style=\"outline: 0px;letter-spacing: 0.544px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     免责声明：\n    </span>\n   </strong>\n   <span style=\"outline: 0px;letter-spacing: 0.544px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     本文仅作信息分享，不代表 Insight 立场和观点，也不作治疗方案推荐和介绍。如有需求，请咨询和联系正规医疗机构。\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk18ic\" style='margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;text-align: left;'>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk111iu\" style='margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;'>\n  <span style=\"outline: 0px;font-size: 12px;color: rgb(178, 178, 178);visibility: visible;\">\n   <strong style=\"outline: 0px;visibility: visible;\">\n    <span leaf=\"\">\n     编辑\n    </span>\n   </strong>\n   <span leaf=\"\">\n    ：ccai\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk1ft9\" style='margin-right: 8px;margin-bottom: 0px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;'>\n  <span style=\"outline: 0px;color: rgb(178, 178, 178);visibility: visible;\">\n   <strong style=\"outline: 0px;visibility: visible;\">\n    <span style=\"outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      PR 稿对接\n     </span>\n    </span>\n   </strong>\n   <span style=\"outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk1maa\" style='margin-right: 8px;margin-bottom: 24px;margin-left: 8px;outline: 0px;letter-spacing: 0.544px;text-indent: 0em;color: rgb(34, 34, 34);font-family: -apple-system, BlinkMacSystemFont, \"Helvetica Neue\", \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei UI\", \"Microsoft YaHei\", Arial, sans-serif;background-color: rgb(255, 255, 255);visibility: visible;line-height: 1.5em;'>\n  <span style=\"outline: 0px;color: rgb(178, 178, 178);visibility: visible;\">\n   <strong style=\"outline: 0px;visibility: visible;\">\n    <span style=\"outline: 0px;font-size: 12px;visibility: visible;\">\n     <span leaf=\"\">\n      投稿\n     </span>\n    </span>\n   </strong>\n   <span style=\"outline: 0px;font-size: 12px;visibility: visible;\">\n    <span leaf=\"\">\n     ：微信 insightxb；邮箱 insight@dxy.cn\n    </span>\n   </span>\n  </span>\n </section>\n <section data-mpa-action-id=\"mcn8unk1zg2\" nodeleaf=\"\" style=\"text-align: center;margin-left: 8px;margin-right: 8px;margin-bottom: 0px;\">\n  <img class=\"rich_pages wxw-img\" data-imgfileid=\"100133180\" data-ratio=\"0.6319148936170212\" data-s=\"300,640\" data-type=\"png\" data-w=\"940\" src=\"/static/res/logo/https://mmbiz.qpic.cn/mmbiz_png/lVFg8Ny0F8vROvmPqd90D6qZZzHhQwNBzyf7pyZ00Jj17v3UdI4lHwH4Wr619icjjBYhbcBFjPCc9Jkib4472Piag/640?wx_fmt=png&amp;from=appmsg\" type=\"block\"/>\n </section>\n <section>\n  <span leaf=\"\">\n   <br/>\n  </span>\n </section>\n <p style=\"display: none;\">\n  <mp-style-type data-value=\"3\">\n  </mp-style-type>\n </p>\n</div>\n",
  "publish_time": 1751587200,
  "mp_id": "MP_WXS_3975077766",
  "pic_url": "https://mmbiz.qlogo.cn/mmbiz_jpg/lVFg8Ny0F8spkkeMz6z17icUbDAyiagMItLDib1tNAaM8yge3lKWaojWTzppgTooXrveQrcicWdR9vYaiaOrpOvPOUw/0?wx_fmt=jpeg",
  "mp_name": "Insight数据库"
}